[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343295-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343295-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","hydrogen-sulfide-releasing-carbonic-anhydrase-inhibitors-effectively-suppress-cancer-cell-growth","Hydrogen Sulfide-Releasing Carbonic Anhydrase Inhibitors Effectively Suppress Cancer Cell Growth","","This study proposes a novel cancer therapeutic strategy combining hydrogen sulfide (H2S) antitumor activity with inhibition of carbonic anhydrases (CAs; EC 4.2.1.1), focusing on isoforms IV, IX, and XII. H2S donors and CA inhibitor (CAI) hybrids were designed to consistently release H2S while effectively inhibiting target CAs. The hybrids show potent in vitro antitumor effects against MDA-MB-231, HCT-116, and A549 cells, disturb the cell cycle, and trigger apoptosis, suggesting versatility for cancer treatment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/hydrogen-sulfide-releasing-carbonic-anhydrase-inhibitors-effectively-suppress-cancer-cell-growth/343295/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/hydrogen-sulfide-releasing-carbonic-anhydrase-inhibitors-effectively-suppress-cancer-cell-growth/343295.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What therapeutic strategy does the study propose for cancer management?","Question",{"text":63,"@type":64},"The study proposes H2S donor–carbonic anhydrase inhibitor (CAI) hybrids that combine H2S antitumor effects with inhibition of carbonic anhydrase isoforms IV, IX, and XII.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do the proposed hybrids affect cancer cells in vitro?",{"text":68,"@type":64},"The hybrids effectively inhibit the targeted CAs, release H2S consistently, disrupt the cell cycle, and induce apoptosis in tested cancer cell lines.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cancer cell lines are reported to be affected by the compounds?",{"text":72,"@type":64},"The abstract reports potent antitumor effects against MDA-MB-231, HCT-116, and A549 cell lines, with some compounds showing high cytotoxicity across the investigated lines.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343295,1790852990,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Article  \nHydrogen Sulfide-Releasing Carbonic Anhydrase Inhibitors Effectively Suppress Cancer Cell Growth  \nAlessandro Bonardi 1, *, Alessio Nocentini 1, *, Viviana de Luca 2, Clemente Capasso 2, Eslam B. Elkaeed 3, Wagdy M. Eldehna 4,5 and Claudiu T. Supuran 1  \nCitation: Bonardi, A.; Nocentini, A.; de Luca, V.; Capasso, C.; Elkaeed, E.B.; Eldehna, W.M.; Supuran, C.T. Hydrogen Sulfide-Releasing Carbonic Anhydrase Inhibitors Effectively Suppress Cancer Cell Growth. Int. J. Mol. Sci. 2024, 25, 10006 .  \n[https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms251810006  \nAcademic Editor: Albrecht Reichle  \nReceived: 5 August 2024  \nRevised: 13 September 2024  \nAccepted: 15 September 2024  \nPublished: 17 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of NEUROFARBA, Pharmaceutical and Nutraceutical Section, University of Firenze, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Florence, Italy; [claudiu.supuran@unifi.it](claudiu.supuran@unifi.it)  \n2 Department of Biology, Agriculture and Food Sciences, National Research Council (CNR), Institute of Biosciences and Bioresources, 80131 Naples, Italy; [viviana.deluca@ibbr.cnr.it](viviana.deluca@ibbr.cnr.it) (V.d.L.); [clemente.capasso@ibbr.cnr.it](clemente.capasso@ibbr.cnr.it) (C.C.)  \n3 Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt; [eslamkaeed@azhar.edu.eg](eslamkaeed@azhar.edu.eg)  \n4 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Pharos University in Alexandria, Canal El Mahmoudia St., Alexandria 21648, Egypt; [wagdy2000@gmail.com](wagdy2000@gmail.com)  \n5 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh 33516, Egypt  \n* Correspondence: alessandro.bonardi@unifi.it (A.B.); alessio.nocentini@unifi.it (A.N.)  \nAbstract: This study proposes a novel therapeutic strategy for cancer management by combining the antitumor effects of hydrogen sulfide (H 2S) and inhibition of carbonic anhydrases (CAs; EC 4.2.1.1), specifically isoforms IV, IX, and XII. H2S has demonstrated cytotoxicity against various cancers at high concentrations. The inhibition of tumor-associated CAs leads to lethal intracellular alkalinization and acidification of the extracellular tumor microenvironment and restores tumor responsiveness to the immune system, chemotherapy, and radiotherapy. The study proposes H 2S donor–CA inhibitor (CAI) hybrids for tumor management. These compounds effectively inhibit the target CAs, release H2S consistently, and exhibit potent antitumor effects against MDA-MB-231, HCT-116, and A549 cancer cell lines. Notably, some compounds display high cytotoxicity across all investigated cell lines. Derivative 30 shows a 2-fold increase in cytotoxicity (0.93 ± 0.02 µM) under chemically induced hypoxia in HCT-116 cells. These compounds also disturb the cell cycle, leading to a reduction in cell populations in G 0/G1 and S phases, with a notable increase in G 2/M and Sub-G1. This disruption is correlated with induced apoptosis, with fold increases of 37.2, 24.5, and 32.9 against HCT-116 cells and 14.2, 13.1, and 19.9 against A549 cells compared to untreated cells. These findings suggest the potential of H 2S releaser–CAI hybrids as effective and versatile tools in cancer treatment.  \nKeywords: hydrogen sulfide; donor; carbonic anhydrase; inhibitor; hybrid; multitarget; tumor; cancer; antitumor; in vitro  \n1. Introduction  \nHypoxia is strongly correlated with tumor growth, malignant progression, nonresponsiveness to the immune system, and resistance to chemotherapy and radiotherapy [1–4] . An oxygen-deprived e","cbCaistcq1V83ZUe","https://ap.wps.com/l/cbCaistcq1V83ZUe","pdf",3030990,17,"English","# Abstract\n# Keywords\n# 1. Introduction\n## Hypoxia, HIF-1, and the Warburg effect","[{\"question\":\"What therapeutic strategy does the study propose for cancer management?\",\"answer\":\"The study proposes H2S donor–carbonic anhydrase inhibitor (CAI) hybrids that combine H2S antitumor effects with inhibition of carbonic anhydrase isoforms IV, IX, and XII.\"},{\"question\":\"How do the proposed hybrids affect cancer cells in vitro?\",\"answer\":\"The hybrids effectively inhibit the targeted CAs, release H2S consistently, disrupt the cell cycle, and induce apoptosis in tested cancer cell lines.\"},{\"question\":\"Which cancer cell lines are reported to be affected by the compounds?\",\"answer\":\"The abstract reports potent antitumor effects against MDA-MB-231, HCT-116, and A549 cell lines, with some compounds showing high cytotoxicity across the investigated lines.\"}]","Hydrogen Sulfide-Releasing Carbonic Anhydrase Inhibitors Effectively Suppress Cancer Cell Growth | PDF",1790050642,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfdc0515dcbab28e6a7251a0da9fda49.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76776df3bdf3ce3e3e2320a3b4709c61.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72f55a26993a1279dfbe6a6d6a6f2b3e.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b449de00af44fcc1bbb48a8d1a81da24.webp",980,1385]